Our Portfolio Medical Devices Medical Devices All Companies Opportunities-II Dice Therapeutics Acquired by Lilly Immunology for patients with debilitating diseases South San Francisco, CA NASDAQ: DICE NLV-III, OPPORTUNITIES-II Harpoon Therapeutics Acquired by Merck Next generation T-cell engaging biologics targeting cancer and other diseases based on its proprietary TriTAC™ platform South San Francisco, CA NASDAQ: HARP NLV–II Altura Medical Acquired by Lombard Medical Developing medical devices for treatment of abdominal aortic aneurysms. Menlo Park, CA NLV–II CardioKinetix Intra-cardiac device implant (PARACHUTE) which treats heart failure by improving overall cardiac function. Menlo Park, CA NLV–II Neuronetics Commercial stage device company with innovative technology for the non-invasive, non-pharmacologic treatment of major depression. Malverne, PA NASD: STIM NLV–II Spiracur Acquired by Acelity/KC1 Commercial stage company with novel devices allowing portable, non-powered products for negative pressure chronic wound therapy. Sunnyvale, CA NLV–II World Heart Acquired by HeartWare Clinical stage company developing a left ventricular assist device for congestive heart failure. Oakland, CA NASDAQ: WHRT NLV–I Access Closure Acquired by Cardinal Health Commercial stage company developing medical devices for vascular closure. Mountain View, CA NLV–I Direct Flow Commercial/Clinical stage company focusing on development of novel percutaneous aortic valves. Santa Rosa, CA NLV–I Illuminoss Medical Clinical stage device company developing innovative percutaneous solutions for fracture repair. East Providence, RI NLV–I Interlace Medical Acquired by Hologic Commercial stage company focused on in-office polypectomy-myomectomy market. Newton, MA NLV–I ReShape Lifesciences Commercial stage device company focused on minimally invasive devices for the treatment of obesity. San Clemente, CA NASDAQ: RSLS Sprout Aspire Medical Developer of medical devices for the treatment of obstructive sleep apnea (OSA). Sunnyvale, CA Sprout Endocardial Solutions Acquired by St. Jude Medical Arrhythmia mapping devices. St. Paul, MN Sprout Epicor Acquired by St. Jude Medical Proprietary cardiac ablation platform to cure atrial fibrillation. Sunnyvale, CA Sprout Intrinsic Therapeutics Late clinical stage company developing novel technology for annulus repair in spine surgery. Woburn, MA Sprout NxStage Medical Commercial stage device company offering treatments for end-stage renal disease that enable home based dialysis therapy. Lawrence, MA NASDAQ: NXTM Sprout Orquest Acquired by DePuy, a Johnson & Johnson company Orthopedic biologic devices. Mountain View, CA Sprout Radiant Medical Acquired by Zoll Proprietary endovascular temperature management systems. Redwood City, CA Sprout Spine Wave Commercial stage device company marketing novel products for spinal fusion. Shelton, CT
Opportunities-II Dice Therapeutics Acquired by Lilly Immunology for patients with debilitating diseases South San Francisco, CA NASDAQ: DICE NLV-III, OPPORTUNITIES-II Harpoon Therapeutics Acquired by Merck Next generation T-cell engaging biologics targeting cancer and other diseases based on its proprietary TriTAC™ platform South San Francisco, CA NASDAQ: HARP NLV–II Altura Medical Acquired by Lombard Medical Developing medical devices for treatment of abdominal aortic aneurysms. Menlo Park, CA NLV–II CardioKinetix Intra-cardiac device implant (PARACHUTE) which treats heart failure by improving overall cardiac function. Menlo Park, CA NLV–II Neuronetics Commercial stage device company with innovative technology for the non-invasive, non-pharmacologic treatment of major depression. Malverne, PA NASD: STIM NLV–II Spiracur Acquired by Acelity/KC1 Commercial stage company with novel devices allowing portable, non-powered products for negative pressure chronic wound therapy. Sunnyvale, CA NLV–II World Heart Acquired by HeartWare Clinical stage company developing a left ventricular assist device for congestive heart failure. Oakland, CA NASDAQ: WHRT NLV–I Access Closure Acquired by Cardinal Health Commercial stage company developing medical devices for vascular closure. Mountain View, CA NLV–I Direct Flow Commercial/Clinical stage company focusing on development of novel percutaneous aortic valves. Santa Rosa, CA NLV–I Illuminoss Medical Clinical stage device company developing innovative percutaneous solutions for fracture repair. East Providence, RI NLV–I Interlace Medical Acquired by Hologic Commercial stage company focused on in-office polypectomy-myomectomy market. Newton, MA NLV–I ReShape Lifesciences Commercial stage device company focused on minimally invasive devices for the treatment of obesity. San Clemente, CA NASDAQ: RSLS Sprout Aspire Medical Developer of medical devices for the treatment of obstructive sleep apnea (OSA). Sunnyvale, CA Sprout Endocardial Solutions Acquired by St. Jude Medical Arrhythmia mapping devices. St. Paul, MN Sprout Epicor Acquired by St. Jude Medical Proprietary cardiac ablation platform to cure atrial fibrillation. Sunnyvale, CA Sprout Intrinsic Therapeutics Late clinical stage company developing novel technology for annulus repair in spine surgery. Woburn, MA Sprout NxStage Medical Commercial stage device company offering treatments for end-stage renal disease that enable home based dialysis therapy. Lawrence, MA NASDAQ: NXTM Sprout Orquest Acquired by DePuy, a Johnson & Johnson company Orthopedic biologic devices. Mountain View, CA Sprout Radiant Medical Acquired by Zoll Proprietary endovascular temperature management systems. Redwood City, CA Sprout Spine Wave Commercial stage device company marketing novel products for spinal fusion. Shelton, CT
